CorMedix Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
CorMedix Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2023 to Q2 2025.
  • CorMedix Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2025 was $806K, a 29.9% decline year-over-year.
  • CorMedix Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2025 was $2.36M.
  • CorMedix Inc. annual Nonoperating Income (Expense) for 2024 was $3.03M, a 15.8% increase from 2023.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $2.36M $806K -$343K -29.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $2.71M $519K -$325K -38.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $3.03M $528K Oct 1, 2024 Dec 31, 2024 10-K 2025-03-25
Q3 2024 $511K -$212K -29.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $1.15M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $843K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q3 2023 $723K Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.